Published in Parasitology on January 01, 1999
Cytokines in the pathogenesis of and protection against malaria. Clin Diagn Lab Immunol (2002) 1.20
Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol Biochem Parasitol (2001) 3.49
Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice. Infect Immun (1993) 2.25
Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes. Neth J Med (2005) 2.10
Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics. Clin Pharmacokinet (1992) 1.74
Clinical pharmacokinetics of dapsone. Clin Pharmacokinet (1986) 1.67
Nitric oxide in cerebral malaria. J Infect Dis (1994) 1.64
Can Babesia infections be used as a model for cerebral malaria? Parasitol Today (1999) 1.53
Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data. Parasitology (2005) 1.44
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose. Biochim Biophys Acta (1997) 1.35
Chemical stability of liposomes: implications for their physical stability. Chem Phys Lipids (1993) 1.24
Interactions between gut-associated lymphoid tissue and colonization levels of indigenous, segmented, filamentous bacteria in the small intestine of mice. Can J Microbiol (1998) 1.22
Oxidative stress in malaria; implications for prevention and therapy. Pharm World Sci (1996) 1.22
Immunological aspects of cerebral lesions in murine malaria. Clin Exp Immunol (1989) 1.16
Adhesion molecules: a new target for immunoliposome-mediated drug delivery. FEBS Lett (1995) 1.16
Plasmodium berghei ANKA: purification of large numbers of infectious gametocytes. Exp Parasitol (1998) 1.15
The effect of a water/organic solvent interface on the structural stability of lysozyme. J Control Release (2000) 1.14
The pharmacokinetics of artemisinin after oral, intramuscular and rectal administration to volunteers. J Pharm Pharmacol (1990) 1.11
Malaria chemosuppression in pregnancy. III. Its effects on the maternal malaria immunity. Trop Geogr Med (1993) 1.09
Plasmodium berghei: recombinant interferon-gamma and the development of parasitemia and cerebral lesions in malaria-infected mice. Exp Parasitol (1993) 1.07
2-(Dimethylamino)ethyl methacrylate based (co)polymers as gene transfer agents. J Control Release (1998) 1.04
Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum. J Biol Chem (2001) 1.04
Effect of DNA topology on the transfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid complexes. J Control Release (1999) 1.03
Pregnancy associated recrudescence in murine malaria (Plasmodium berghei). Tropenmed Parasitol (1980) 1.02
Low dosages of interleukin 1 protect mice against lethal cerebral malaria. J Exp Med (1990) 1.01
Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model. Cancer Res (1987) 1.01
Effect of size and serum proteins on transfection efficiency of poly ((2-dimethylamino)ethyl methacrylate)-plasmid nanoparticles. Pharm Res (1996) 1.01
Morphological characteristics of intracerebral arterioles in clinical (Plasmodium falciparum) and experimental (Plasmodium berghei) cerebral malaria. J Neurol Sci (1991) 1.00
Physical (in) stability of liposomes upon chemical hydrolysis: the role of lysophospholipids and fatty acids. Biochim Biophys Acta (1995) 1.00
Convulsions due to increased permeability of the blood-brain barrier in experimental cerebral malaria can be prevented by splenectomy or anti-T cell treatment. J Infect Dis (1998) 1.00
The role of protein charge in protein-lipid interactions. pH-dependent changes of the electrophoretic mobility of liposomes through adsorption of water-soluble, globular proteins. Biochemistry (1993) 1.00
Correlation between nasal ciliary beat frequency and mucus transport rate in volunteers. Laryngoscope (1985) 0.99
Sterically stabilized liposomes labeled with indium-111 to image focal infection. J Nucl Med (1995) 0.99
Liposomes and ISCOMS as vaccine formulations. Biochim Biophys Acta (1995) 0.99
Leukocytes in a Plasmodium falciparum-infected blood meal reduce transmission of malaria to Anopheles mosquitoes. Infect Immun (1997) 0.99
The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration. Int J Pharm (2001) 0.97
Depressed malarial immunity in pregnant mice. Infect Immun (1980) 0.97
On the structure of immune-stimulating saponin-lipid complexes (iscoms). Biochim Biophys Acta (1991) 0.96
In vitro development of infectious liver stages of P. yoelii and P. berghei malaria in human cell lines. Exp Parasitol (1994) 0.96
The preparation of tissue-type Plasminogen Activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage. J Drug Target (1995) 0.94
Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes. Infect Immun (1986) 0.94
Dietary fish-oil supplementation in experimental gram-negative infection and in cerebral malaria in mice. J Infect Dis (1992) 0.94
Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. Biochim Biophys Acta (1999) 0.94
Liposomes as sustained release system for human interferon-gamma: biopharmaceutical aspects. Biochim Biophys Acta (2001) 0.93
The influence of the pH and osmotic pressure upon tracheal ciliary beat frequency as determined with a new photo-electric registration device. Rhinology (1980) 0.92
Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques. J Control Release (2000) 0.92
Cellular uptake of liposomes targeted to intercellular adhesion molecule-1 (ICAM-1) on bronchial epithelial cells. Biochim Biophys Acta (1999) 0.92
Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes. J Nucl Med (1996) 0.91
Immunization against cerebral pathology in Plasmodium berghei-infected mice. Parasitology (1992) 0.91
Endomyocardial lesion and endomyocardial fibrosis in experimental malaria (Plasmodium berghei) in mice. Contrib Microbiol Immunol (1983) 0.91
Separation of parasitized erythrocytes from Plasmodium berghei infected mouse blood. Trans R Soc Trop Med Hyg (1977) 0.90
Chemical hydrolysis of phospholipids. J Pharm Sci (1995) 0.90
Cortisol and Plasmodium falciparum infection in pregnant women in Kenya. Trans R Soc Trop Med Hyg (1990) 0.89
Malaria immunity and premunition in a Plasmodium berghei mouse model. Isr J Med Sci (1978) 0.89
Hydrolysis of saturated soybean phosphatidylcholine in aqueous liposome dispersions. J Pharm Sci (1993) 0.89
Circulating tumour necrosis factor alpha is not involved in the development of cerebral malaria in Plasmodium berghei-infected C57Bl mice. Parasite Immunol (1997) 0.88
Bioavailability of propranolol after oral, sublingual, and intranasal administration. Pharm Res (1986) 0.88
The pharmacokinetics of dapsone after oral administration to healthy volunteers. Br J Clin Pharmacol (1986) 0.88
Preparation of liposomes via detergent removal from mixed micelles by dilution. The effect of bilayer composition and process parameters on liposome characteristics. Pharm Weekbl Sci (1986) 0.88
Short term stability of freeze-dried, lyoprotected liposomes. J Control Release (1999) 0.88
The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation. Biochim Biophys Acta (1985) 0.88
Plasmodium berghei: effect of antithymocyte serum on induction of immunity in the mouse. Exp Parasitol (1979) 0.87
Cortisol and loss of malaria immunity in human pregnancy. Br J Obstet Gynaecol (1987) 0.87
The use of aqueous PEG/dextran phase separation for the preparation of dextran microspheres. Int J Pharm (1999) 0.87
The effects of nasal drops and their additives on human nasal mucociliary clearance. Rhinology (1982) 0.87
Ultrastructural changes in the blood-brain barrier of mice infected with Plasmodium berghei. Acta Leiden (1992) 0.87
Chronic, patent Plasmodium berghei malaria in splenectomized mice. Infect Immun (1982) 0.87
Reduced adrenal response to bacterial lipopolysaccharide in interleukin-6-deficient mice. J Endocrinol Invest (2001) 0.86
Colloidal systems for tumor targeting. Hybridoma (1997) 0.86
Fourier transform infrared spectrometric analysis of protein conformation: effect of sampling method and stress factors. Anal Biochem (2001) 0.86
Tumour necrosis factor-alpha and macrophages in Plasmodium berghei-induced cerebral malaria. Parasitology (1993) 0.86
Chloroquine containing liposomes in the chemotherapy of murine malaria. Parasitology (1989) 0.86
The effect of aging on the physical stability of liposome dispersions. Chem Phys Lipids (1992) 0.86
In vivo resorption of a biodegradable polyurethane foam, based on 1,4-butanediisocyanate: a three-year subcutaneous implantation study. J Biomed Mater Res A (2008) 0.85
Immunological properties of recombinant proteins of the transmission blocking vaccine candidate, Pfs48/45, of the human malaria parasite Plasmodium falciparum produced in Escherichia coli. Parasite Immunol (1998) 0.85
Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat. Cancer Res (1984) 0.85
Effects of interleukin-8 on nonspecific resistance to infection in neutropenic and normal mice. Antimicrob Agents Chemother (1993) 0.85
Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines. Pharm Res (2000) 0.85
Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA. Thromb Haemost (1995) 0.85
Role of spleen in morbidity and mortality of Plasmodium berghei infection in mice. Infect Immun (1980) 0.84
Dietary n-3 fatty acids increase spleen size and postendotoxin circulating TNF in mice; role of macrophages, macrophage precursors, and colony-stimulating factor-1. J Immunol (1996) 0.84
Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo. Br J Cancer (1996) 0.84
Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells. Cancer Gene Ther (2001) 0.84
The preparation of dextran microspheres in an all-aqueous system: effect of the formulation parameters on particle characteristics. Pharm Res (1998) 0.84
Analytical approaches to the study of monoclonal antibody stability. Pharm Res (1990) 0.84
Role of macrophages in the pathogenesis of endomyocardial fibrosis in murine malaria. Trans R Soc Trop Med Hyg (1984) 0.84
Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice. Infect Immun (1994) 0.84
Hydrolysis of partially saturated egg phosphatidylcholine in aqueous liposome dispersions and the effect of cholesterol incorporation on hydrolysis kinetics. J Pharm Pharmacol (1993) 0.84
Plasmodium berghei: premunition, sterile immunity, and loss of immunity in mice. Exp Parasitol (1980) 0.84
In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice. Cancer Res (1992) 0.83
Release of doxorubicin from peritoneal macrophages exposed in vivo to doxorubicin-containing liposomes. Biochim Biophys Acta (1988) 0.83